Ryan Charles S. 4
4 · Quince Therapeutics, Inc. · Filed Sep 6, 2023
Insider Transaction Report
Form 4
Ryan Charles S.
President
Transactions
- Award
Employee Stock Option (right to buy)
2023-09-01+545,000→ 545,000 totalExercise: $1.30Exp: 2033-08-31→ Common Stock (545,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the option will vest one year after the date of the grant of September 1, 2023 and the remaining shares will vest in equal monthly installments over the following three years thereafter.